A new Nature study shows that the dosage of a single transfer RNA, tRNA1Arg(UCU), acts as a reversible molecular switch ...

The New York Proton Center in East Harlem is the first and only proton therapy center in New York State, but often brings its ...

Researchers at KTH Royal Institute of Technology used multi-omics analysis and machine learning to uncover molecular features ...

Men newly diagnosed with prostate cancer face a range of treatment options, from robotic surgery and focal therapy to ...

New research highlights improvement in survival and the need for new drug treatments to reach everyone who could benefitMen ...

September marked Ovarian Cancer Awareness Month, but the need for greater research, better treatment, and improved early ...

Although the number of men being diagnosed with the disease continues to rise, medical advances have led to a significant ...

Men in England diagnosed with incurable advanced prostate cancer are more likely to survive for at least three years than ...

Myriad Genetics ( MYGN) and SOPHiA GENETICS ( SOPH) announced a collaboration with AstraZeneca ( AZN) to advance a new prostate cancer-specific genomic instability score, or PrGIS, for precision ...

The Prostate Cancer Foundation (PCF) today announced the publication of a new consensus framework designed to help clinicians ...

SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) today announce a collaboration to advance new ...

"The number of men living with prostate cancer also continues to rise, so it's vital that we see investment in prostate ...